目次

Table of Contents

1. Gastric Cancer Drugs Market Executive Summary

2. Table of Contents

3. List of Figures

4. List of Tables

5. Report Structure

6. Introduction
6.1.1.Segmentation By Geography
6.1.2. Segmentation By Type
6.1.3.Segmentation By End-User
6.1.4. Segmentation By Route Of Administration

7. Gastric Cancer Drugs Market Characteristics
7.1. Market Definition
7.2. Market Segmentation By Type
7.2.1. Imatinib
7.2.2.Trastuzumab
7.2.3. Others
7.3. Market Segmentation By End-User
7.3.1. Hospital
7.3.2. Clinics
7.3.3. Speciality Cancer Centers
7.4. Market Segmentation By Route Of Administration
7.4.1. Oral
7.4.2.Parenteral

8. Gastric Cancer Drugs Market Trends And Strategies
8.1. Strategic Collaborations And Agreements
8.2. Global Research Initiatives And Funding
8.3. Increasing Number Of Pipeline Studies And Drug Development
8.4. Investment In Artificial Intelligence
8.5. Development And Increasing Demand For Next Generation Biologics
8.6. CRISPR-Cas9 Technology Use In Gastric Cancer Treatment
8.7. Use Of 3D Printing To Test New Drugs

9. COVID-19 Impact On The Gastric Cancer Drugs Market
9.1. Clinical Trial Delays
9.2. Low Usage Of Drugs
9.3. Supply Chain Issues
9.4. Shortage In Resources

10. Global Gastric Cancer Drugs Market Size And Growth
10.1. Market Size
10.2. Historic Market Growth, 2015 - 2020, Value ($ Million)
10.2.1. Drivers Of The Market 2015 - 2020
10.2.2. Restraints On The Market 2015 - 2020
10.3. Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
10.3.1. Drivers Of The Market 2020 - 2025
10.3.2. Restraints On The Market 2020 - 2025

11. Global Gastric Cancer Drugs Market Segmentation
11.1.Global Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.1.1. Trastuzumab
11.1.2. Others
11.1.3. Imatinib
11.2. Global Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
11.2.1. Hospitals
11.2.2. Cancer Specialty Centers
11.2.3. Clinics

12. Gastric Cancer Drugs Market, Regional And Country Analysis
12.1. Global Gastric Cancer Drugs Market, By Region, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.2. Global Gastric Cancer Drugs Market, By Country, Historic and Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.3. Global Gastric Cancer Drugs Market, Segmentation By Route Of Administration, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
12.3.1. Parenteral
12.3.2. Oral

13. Asia-Pacific Gastric Cancer Drugs Market
13.1.Asia-Pacific Gastric Cancer Drugs Market Overview
13.1.1. Region Information
13.1.2. Market Information
13.1.3. COVID-19 Impact
13.1.4. Background Information
13.1.5. Government Initiatives
13.1.6. Regulations
13.1.7. Regulatory Bodies
13.1.8. Major Associations
13.1.9. Taxes Levied
13.1.10. Corporate Tax Structure
13.1.11. Investments
13.1.12. Major Companies
13.2. Asia-Pacific Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.3.Asia-Pacific Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.4. Asia-Pacific Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.5.Asia-Pacific Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.6. Asia-Pacific Gastric Cancer Drugs Market: Country Analysis
13.7. China Gastric Cancer Drugs Market
13.8. China Gastric Cancer Drugs Market Overview
13.8.1. Country Information
13.8.2. Market Information
13.8.3. COVID-19 Impact
13.8.4. Background information
13.8.5. Government Initiatives
13.8.6. Regulations
13.8.7. Regulatory Bodies
13.8.8. Major Associations
13.8.9. Taxes levied
13.8.10. Corporate tax structure
13.8.11. Investments
13.8.12. Major Companies
13.9. China Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.10. China Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.11. China Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.12. China Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.13. India Gastric Cancer Drugs Market
13.14. India Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.15. India Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.16. India Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.17. India Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.18. Japan Gastric Cancer Drugs Market
13.19. Japan Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.20. Japan Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.21. Japan Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.22. Japan Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.23. Australia Gastric Cancer Drugs Market
13.24. Australia Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.25. Australia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.26. Australia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.27. Australia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.28. Indonesia Gastric Cancer Drugs Market
13.29. Indonesia Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.30. Indonesia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.31. Indonesia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.32. Indonesia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.33. South Korea Gastric Cancer Drugs Market
13.34. South Korea Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
13.35. South Korea Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
13.36. South Korea Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
13.37. South Korea Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

14. Western Europe Gastric Cancer Drugs Market
14.1. Western Europe Gastric Cancer Drugs Market Overview
14.1.1. Region Information
14.1.2. Market Information
14.1.3. COVID-19 Impact
14.1.4. Background Information
14.1.5. New Drug Approvals
14.1.6. Government Initiatives
14.1.7. Regulations
14.1.8. Regulatory Bodies
14.1.9. Major Associations
14.1.10. Taxes Levied
14.1.11. Corporate Tax Structure
14.1.12. Investment
14.1.13. Major Companies
14.2. Western Europe Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.3. Western Europe Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.4. Western Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.5. Western Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.6. Western Europe Gastric Cancer Drugs Market: Country Analysis
14.7.UK Gastric Cancer Drugs Market
14.8. UK Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.9. UK Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.10. UK Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.11. UK Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.12. Germany Gastric Cancer Drugs Market
14.13. Germany Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.14. Germany Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.15. Germany Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.16. Germany Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.17. France Gastric Cancer Drugs Market
14.18. France Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
14.19. France Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
14.20. France Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
14.21. France Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

15. Eastern Europe Gastric Cancer Drugs Market
15.1.Eastern Europe Gastric Cancer Drugs Market Overview
15.1.1. Region Information
15.1.2. Market Information
15.1.3. COVID-19 Impact
15.1.4. Background Information
15.1.5. New Drug Approvals
15.1.6. Government Initiatives
15.1.7. Regulations
15.1.8. Regulatory Bodies
15.1.9. Major Associations
15.1.10. Taxes Levied
15.1.11. Corporate Tax Structure
15.1.12. Investments
15.1.13. Major Companies
15.2. Eastern Europe Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.3.Eastern Europe Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.4. Eastern Europe Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.5.Eastern Europe Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.6. Eastern Europe Gastric Cancer Drugs Market: Country Analysis
15.7. Russia Gastric Cancer Drugs Market
15.8. Russia Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
15.9. Russia Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
15.10. Russia Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
15.11. Russia Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

16. North America Gastric Cancer Drugs Market
16.1. North America Gastric Cancer Drugs Market Overview
16.1.1. Region Information
16.1.2. Market Information
16.1.3. COVID-19 Impact
16.1.4. Background Information
16.1.5. New Drug Approvals
16.1.6. Government Initiatives
16.1.7. Regulations
16.1.8. Regulatory Bodies
16.1.9. Major Associations
16.1.10. Taxes levied
16.1.11. Corporate Tax Structure
16.1.12. Investments
16.1.13. Major Companies
16.2. North America Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.3. North America Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.4. North America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.5. North America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.6. North America Gastric Cancer Drugs Market: Country Analysis
16.7.USA Gastric Cancer Drugs Market
16.8. USA Gastric Cancer Drugs Market Overview
16.8.1. Region Information
16.8.2. Market Information
16.8.3. COVID-19 Impact
16.8.4. Background Information
16.8.5. New Drug Approvals
16.8.6. Government Initiatives
16.8.7. Regulations
16.8.8. Regulatory Bodies
16.8.9. Major Associations
16.8.10. Taxes levied
16.8.11. Corporate Tax Structure
16.8.12. Investment
16.8.13. Major Companies
16.9. USA Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
16.10. USA Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
16.11. USA Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
16.12. USA Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

17. South America Gastric Cancer Drugs Market
17.1. South America Gastric Cancer Drugs Market Overview
17.1.1. Region Information
17.1.2. COVID-19 Impact
17.1.3. Market Information
17.1.4. Background Information
17.1.5. New Drug Approvals
17.1.6. Government Initiatives
17.1.7. Regulations
17.1.8. Regulatory Bodies
17.1.9. Major Associations
17.1.10. Taxes Levied
17.1.11. Corporate Tax Structure
17.1.12. Investments
17.1.13. Major Companies
17.2.South America Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.3. South America Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.4.South America Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.5. South America Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.6.South America Gastric Cancer Drugs Market: Country Analysis
17.7. Brazil Gastric Cancer Drugs Market
17.8.Brazil Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
17.9.Brazil Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
17.10. Brazil Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
17.11. Brazil Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

18. Middle East Gastric Cancer Drugs Market
18.1. Middle East Gastric Cancer Drugs Market Overview
18.1.1. Region Information
18.1.2. Market Information
18.1.3. COVID-19 Impact
18.1.4. Background Information
18.1.5. Government Initiatives
18.1.6. Regulations
18.1.7. Regulatory Bodies
18.1.8. Major Associations
18.1.9. Taxes levied
18.1.10. Corporate Tax Structure
18.1.11. Investment
18.1.12. Major Companies
18.2. Middle East Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
18.3. Middle East Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030F Value ($ Million)
18.4. Middle East Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
18.5. Middle East Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

19. Africa Gastric Cancer Drugs Market
19.1. Africa Gastric Cancer Drugs Market Overview
19.1.1. Region Information
19.1.2. Market Information
19.1.3. COVID-19 Impact
19.1.4. Background Information
19.1.5. Government Initiatives
19.1.6. Regulations
19.1.7. Regulatory Bodies
19.1.8. Major Associations
19.1.9. Taxes levied
19.1.10. Corporate Tax Structure
19.1.11. Investment
19.1.12. Major Companies
19.2. Africa Gastric Cancer Drugs Market, Historic Market Growth, 2015 - 2020, Value ($ Million)
19.3. Africa Gastric Cancer Drugs Market, Forecast Market Growth, 2020 - 2025, 2030FValue ($ Million)
19.4. Africa Gastric Cancer Drugs Market, Segmentation By Type, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)
19.5. Africa Gastric Cancer Drugs Market, Segmentation By End User, Historic And Forecast, 2015 - 2020, 2025F, 2030F, Value ($ Million)

20. Global Gastric Cancer Drugs Market Competitive Landscape
20.1. Company Profiles
20.2. F. Hoffmann-La Roche Ltd
20.2.1. Company Overview
20.2.2. Products And Services
20.2.3. Financial Overview
20.3. Eli Lilly And Company
20.3.1. Company Overview
20.3.2. Products And Services
20.3.3. Business Strategy
20.3.4. Financial Overview
20.4. Otsuka Pharmaceutical
20.4.1. Company Overview
20.4.2. Products And Services
20.4.3. Business Strategy
20.4.4. Financial Overview
20.5. Jiangsu HengRui Medicine
20.5.1. Company Overview
20.5.2. Products And Services
20.5.3. Business Strategy
20.5.4. Financial Overview
20.6. Biocon
20.6.1. Company Overview
20.6.2. Products And Services
20.6.3. Business Strategy
20.6.4. Financial Overview

21. Gastric Cancer Drugs Pipeline Analysis

22. Key Mergers And Acquisitions In The Gastric Cancer Drugs Market
22.1. Compass Therapeutics, Inc. Acquired TRIGR Therapeutics, Inc.
22.2. Agilent Technologies Acquired Resolution Bioscience
22.3. Amgen Inc. Acquired Five Prime Technologies
22.4. Takeda Pharmaceutical Co. Acquired Maverick Therapeutics
22.5. Pfizer Acquired Array Biopharma
22.6. Eli Lilly Acquired Loxo Oncology

23. Gastric Cancer Drugs Market Opportunities And Strategies
23.1. Global Gastric Cancer Drugs Market In 2025 - Countries Offering Most New Opportunities
23.2. Global Gastric Cancer Drugs Market In 2025 - Segments Offering Most New Opportunities
23.3. Global Gastric Cancer Drugs Market In 2025 - Growth Strategies
23.3.1. Market Trend Based Strategies
23.3.2. Competitor Strategies

24. Gastric Cancer Drugs Market, Conclusions And Recommendations
24.1. Conclusions
24.2. Recommendations
24.2.1. Product
24.2.2. Price
24.2.3. Place
24.2.4. Promotion
24.2.5. People

25. Appendix
25.1. Market Data Sources
25.2. Research Methodology
25.3. Currencies
25.4. Research Inquiries
25.5. The Business Research Company
25.6. Copyright and Disclaimer